{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:08:55Z","timestamp":1767859735548,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["15140432"],"award-info":[{"award-number":["15140432"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.049","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:02:28Z","timestamp":1530126148000},"page":"4610-4620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong"],"prefix":"10.1016","volume":"36","author":[{"given":"Joyce H.S.","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-kit","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chak-fei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen Tak-yin","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Kay-sheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.049_b0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.vaccine.2009.11.029","article-title":"Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan","volume":"28","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.049_b0010","unstructured":"Census and Statistics Department, Hong Kong SAR. Women and men in Hong Kong key statistics 2017 Edition. Website: <https:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp180.jsp?productCode=B1130303> [assessed on 2 August 2017]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0015","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.049_b0020","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2018.06.049_b0025","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.049_b0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.049_b0035","unstructured":"Centers for Disease Control and Prevention. Singles (Herpes Zoster) vaccination. Website: <https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/index.html> [assessed on 9 November 2017]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0040","unstructured":"The World Bank. GDP per capital (current US$) Data. Website: Cap. <https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD> [accessed on 23 May 2018]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0045","unstructured":"World Health Organization. Global Health Observatory (GHO) data. Website: <http:\/\/www.who.int\/gho\/mortality_burden_disease\/life_tables\/situation_trends\/en\/> [accessed on 23 May 2018]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","article-title":"Herpes zoster in Germany: quantifying the burden of disease","volume":"11","author":"Ultsch","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.049_b0055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2340\/00015555-0729","article-title":"Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006","volume":"89","author":"Jih","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"7264","key":"10.1016\/j.vaccine.2018.06.049_b0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up","volume":"321","author":"Helgason","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.06.049_b0065","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.vaccine.2018.06.049_b0070","unstructured":"Overview of two economic models that assess the cost-effectiveness of herpes zoster vaccinations. Advisory Committee on Immunization Practices June 21, 2017. Webste: <https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2017-06\/zoster-04-leidner.pdf> [assessed on 9 November 2017]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values","volume":"36","author":"Gold","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.049_b0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","article-title":"Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey","volume":"6","author":"Oster","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.vaccine.2018.06.049_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","article-title":"Postherpetic neuralgia\u2013pathogenesis, treatment, and prevention","volume":"335","author":"Kost","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.049_b0090","unstructured":"Census and Statistics Department, Hong Kong SAR. Hong Kong life tables 2011\u20132066. Website: <https:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp190.jsp?productCode=B1120016> [assessed on 2 August 2017]."},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.049_b0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamainternmed.2017.7431","article-title":"Cost-effectiveness of the adjuvanted herpes zoster subunit vaccine in older adults","volume":"178","author":"Le","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2018.06.049_b0100","series-title":"Reducing risks, promoting healthy life","first-page":"2002","author":"The world health report","year":"2002"},{"key":"10.1016\/j.vaccine.2018.06.049_b0105","unstructured":"Census and Statistics Department, The Government of Hong Kong SAR. National income. Website: <http:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp250.jsp?tableID=030&ID=0&productType=8> [accessed on 15 August 2017]."},{"key":"10.1016\/j.vaccine.2018.06.049_b0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1472-6963-13-359","article-title":"Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany","volume":"13","author":"Ultsch","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2018.06.049_b0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost\u2013effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.06.049_b0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.06.049_b0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/21645515.2015.1011016","article-title":"Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong \u2013 a decision analysis","volume":"11","author":"You","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.06.049_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10198-014-0652-y","article-title":"Estimating productivity costs using the friction cost approach in practice: a systematic review","volume":"17","author":"Kigozi","year":"2016","journal-title":"Eur J Health Econ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:14Z","timestamp":1759400774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18308909"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}